These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 859038)

  • 21. Bone marrow scan evaluation of arthropathy in sickle cell disorders.
    Alavi A; Schumacher HR; Dorwart B; Kuhl DE
    Arch Intern Med; 1976 Apr; 136(4):436-40. PubMed ID: 1267551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tc-99m phytate bone marrow scintigraphy showing multiple areas of focal hyperactivity in a patient with lung cancer. A case report.
    Chang CP; Chu LS; Liu RS; Yu SM; Yeh SH
    Clin Nucl Med; 1995 Jun; 20(6):501-4. PubMed ID: 7648731
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A new formulation of Tc-99m minimicroaggregated albumin for marrow imaging: comparison with other colloids, In-111 and Fe-59.
    McAfee JG; Subramanian G; Aburano T; Thomas FD; Fernandes P; Gagne G; Lyons B; Zapf-Longo C
    J Nucl Med; 1982 Jan; 23(1):21-8. PubMed ID: 6459431
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis, radiotechnetium labelling, and comparison of biologic behavior of longer-chain analogs of methylene diphosphonate.
    Wang TS; Hosain P; Spencer RP; Ahlquist K; Hosain F
    J Nucl Med; 1978 Oct; 19(10):1151-3. PubMed ID: 722328
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Properties of technetium Tc 99m phytate complex--studies in vivo and in vitro].
    Popowska E; Bałtrukiewicz Z
    Rocz Panstw Zakl Hig; 1984; 35(2):181-9. PubMed ID: 6484460
    [No Abstract]   [Full Text] [Related]  

  • 26. A study of the relationship between chemical structure and bone localization of Tc-99m diphosphonic acids: concise communication.
    Wang TS; Mojdehi GE; Fawwaz RA; Johnson PM
    J Nucl Med; 1979 Oct; 20(10):1066-70. PubMed ID: 536757
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Local blood flow and bone uptake of methylene-diphosphonate-technetium-99m. 2].
    Vattimo A; Martini G
    Boll Soc Ital Biol Sper; 1983 Nov; 59(11):1614-7. PubMed ID: 6230088
    [No Abstract]   [Full Text] [Related]  

  • 28. A comparison of skeletal uptakes of three diphosphonates by whole-body retention: concise communication.
    Fogelman I; Pearson DW; Bessent RG; Tofe AJ; Francis MD
    J Nucl Med; 1981 Oct; 22(10):880-3. PubMed ID: 6457135
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Evaluation of multiple myeloma with bone scintigraphy using Tc 99 diphosphonate. Review of the literature].
    Solis OJ; Gonzales R; De Luca S; McKusick KA; Potsaid MS
    Rev Interam Radiol; 1977 Apr; 2(2):71-5. PubMed ID: 866897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical evaluation of the bone marrow imaging agent 99Tcm-phytate in the detection of bone metastases.
    Chang CP; Liu RS; Yu SM; Wynchank S; Chu LS; Shiau HY; Cheng TC
    Nucl Med Commun; 1996 Dec; 17(12):1030-4. PubMed ID: 9004298
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The evolution of methods for the preparation of technetium-99m sulfur colloid.
    Richards LP; Ege GN
    Am J Hosp Pharm; 1970 Oct; 27(10):827-31. PubMed ID: 5473473
    [No Abstract]   [Full Text] [Related]  

  • 32. A crossover study comparing the effect of particle size on the distribution of radiocolloid in patients.
    Kloiber R; Damtew B; Rosenthall L
    Clin Nucl Med; 1981 May; 6(5):204-6. PubMed ID: 6452980
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential skeletal uptake of Tc-99m-tagged pyrophosphate and methylene diphosphonate in leukemia.
    Armas R; Neumann R; Goldsmith SJ
    J Nucl Med; 1983 Sep; 24(9):799-802. PubMed ID: 6310070
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors affecting distribution of technetium-sulfur colloid.
    Atkins HL; Hauser W; Richards P
    J Reticuloendothel Soc; 1970 Aug; 8(2):176-84. PubMed ID: 5469817
    [No Abstract]   [Full Text] [Related]  

  • 35. Sites and mechanisms of localization of technetium-99m phosphorus radiopharmaceuticals in acute myocardial infarcts and other tissues.
    Buja LM; Tofe AJ; Kulkarni PV; Mukherjee A; Parkey RW; Francis MD; Bonte FJ; Willerson JT
    J Clin Invest; 1977 Sep; 60(3):724-40. PubMed ID: 893676
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is (99m)Tc-labelled pamidronate a better agent than (99m)Tc-medronate for bone imaging?
    Kumar V; Kumar D; Howman-Giles RB; Little DG
    Nucl Med Commun; 2007 Feb; 28(2):101-7. PubMed ID: 17198350
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preparation, distribution and utilization of technetium-99m-sulfur colloid.
    Stern HS; McAfee JG; Subramanian G
    J Nucl Med; 1966 Sep; 7(9):665-75. PubMed ID: 5921170
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical and experimental evaluation of osteotropic radiopharmaceutical preparations].
    Korsunskiĭ VN; Tarasov NF; Koval'chuk ND; Levin VI; Boldyrev PP
    Med Radiol (Mosk); 1980 Sep; 25(9):9-13. PubMed ID: 6252408
    [No Abstract]   [Full Text] [Related]  

  • 39. Inflammatory lesions localized with technetium Tc 99m-labeled leukocytes.
    Andersen BR; English D; Akalin HE; Henderson W
    Arch Intern Med; 1975 Aug; 135(8):1067-71. PubMed ID: 1156068
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New preparation method for 99mTc-phytate.
    Ikeda I; Inoue O; Kurata K
    J Nucl Med; 1976 May; 17(5):389-93. PubMed ID: 1262944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.